New pill targets cancer motor protein in first human trial
Disease control
Recruiting now
This early-phase study tests an experimental pill called ATX-295 in people with advanced solid tumors, including ovarian and breast cancers that have not responded to standard treatments. The drug works by blocking a protein (KIF18A) that cancer cells need to divide. The main goa…
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated May 17, 2026 06:49 UTC